Best Dealpath Alternatives for CRE Investment Teams (2026)

Why Teams Explore Alternatives

Dealpath is the leading deal management and pipeline tracking platform for institutional real estate investment firms. It organizes deals through your pipeline, tracks team activity, manages approvals, and provides reporting on deal flow. For firms managing 50+ active opportunities, Dealpath brings structure to that process.

Teams search for Dealpath alternatives for different reasons — and the right alternative depends on which problem they're actually trying to solve:

• The analytics gap. Dealpath tracks deals but doesn't analyze them. Teams want the underwriting and modeling capabilities that pipeline management doesn't provide.
• Cost. Enterprise deal management platforms can be expensive for smaller teams that need pipeline visibility without the full feature set.
• Integration. Teams want their deal tracking and deal analysis in the same system, not in two disconnected tools.
• LP reporting. Some teams searching for Dealpath alternatives actually need investor relations and fund management tools — a different category entirely.

What to Look For

Before evaluating alternatives, clarify which of these you actually need:

1. Pipeline tracking and visibility. Where is each deal? Who's assigned? What stage? This is Dealpath's core — and most alternatives don't replace it.
2. Deal analysis and modeling. Building financial models, running sensitivity analysis, sizing debt. This is what Dealpath doesn't do, and what many teams actually need.
3. Document processing. Going from broker PDFs to structured data. Dealpath stores documents; it doesn't read them.
4. LP/investor reporting. Fund-level reporting, capital calls, distribution notices. A different category from deal management.
5. Approval workflows. Multi-stage review and approval processes for screening committees and IC.

Feature Comparison

Table 1 — Dealpath vs. alternatives across capabilities. Each tool solves a different part of the institutional workflow.

Apers

Apers is not a Dealpath replacement — it solves a different problem. Where Dealpath answers "where is each deal in our pipeline?", Apers answers "should we do this deal?" by generating complete financial models from deal documents.

When Apers is what you actually need:

• Your bottleneck is underwriting speed, not pipeline visibility
• You need to go from PDF to populated Excel model
• You need waterfall modeling, debt sizing, or LIHTC analysis
• Your team can't model deals fast enough to keep up with deal flow

When you need both: Many institutional teams use Dealpath for pipeline management and Apers for the analytical work inside each deal. Deals enter the pipeline in Dealpath; models are built in Apers; outputs feed back to Dealpath as deal metadata. See our Apers vs. Dealpath comparison for the detailed workflow.

Juniper Square

Juniper Square is an investor management and fund administration platform for real estate GPs. It handles capital calls, distribution notices, investor portals, K-1 delivery, and fund reporting.

When Juniper Square is what you actually need:

• Your pain is LP reporting and investor communication, not deal tracking
• You need capital call and distribution automation
• You want an investor portal where LPs can see fund performance

Juniper Square doesn't compete with Dealpath on pipeline management or with Apers on underwriting. It serves the GP operations team, not the acquisitions team.

Blooma

Blooma is a deal management platform designed specifically for CRE lenders. It handles loan origination, deal screening, portfolio monitoring, and risk management from a lender's perspective.

When Blooma is what you actually need:

• You're a CRE lender, not an equity investor
• You need loan origination workflows and credit risk assessment
• You need portfolio monitoring from a debt perspective

If you're on the equity side — PE funds, family offices, acquisitions teams — Blooma's lender focus won't match your workflow.

Shared Spreadsheets

The most common Dealpath alternative is what most teams used before Dealpath: a shared Google Sheet or Excel file tracking deals.

Strengths: Free, familiar, infinitely flexible. For teams tracking fewer than 20 active deals, a well-maintained spreadsheet often works fine.

When it breaks down:

• Deal volume exceeds what one person can maintain in a spreadsheet
• Multiple team members need to update deal status simultaneously
• Management needs reporting that's more reliable than "check the sheet"
• Approval workflows require audit trails

If your team has outgrown spreadsheets but can't justify Dealpath's price, the question is whether to invest in pipeline management (Dealpath) or analytical capability (Apers) first. For most acquisitions teams, the analytical bottleneck is more painful than the tracking bottleneck.

When to Stay with Dealpath

Dealpath remains the right choice when:

• Pipeline visibility is the primary pain. You have 50+ active deals and management can't see where things stand. Dealpath solves this directly.
• Approval workflows matter. Multi-stage review processes with role-based permissions and audit trails. Dealpath's workflow engine is mature here.
• Cross-deal reporting. "How many multifamily deals did we screen this quarter? What's our average time from screening to LOI?" Pipeline analytics across your deal book.
• Team coordination. Task assignment, activity tracking, and CRM-adjacent broker relationship management alongside your pipeline.

Verdict

The right Dealpath alternative depends on what you're actually missing:

• Missing analytics and modeling? → Apers — from documents to IC-ready models
• Missing LP reporting? → Juniper Square — investor management and fund admin
• Missing lending workflows? → Blooma — CRE lender deal management
• Missing nothing, just want cheaper? → Shared spreadsheets for small teams

Most teams searching for "Dealpath alternatives" aren't looking to replace pipeline tracking — they're looking for the analytical capabilities that pipeline tracking doesn't provide. If that's your situation, the answer isn't a Dealpath replacement. It's a Dealpath complement.

Related Comparisons

• Apers vs. Dealpath — detailed head-to-head
• Best AI for CRE Underwriting — category guide
• Best ARGUS Alternatives — for teams evaluating modeling tools